Harrison W. Farber, MD, is Professor of Medicine and Director of the Pulmonary Hypertension Center at Boston University/Boston Medical Center. With a research focus on endothelial cell biology, his laboratory is investigating the response of the pulmonary vasculature in different etiologies of pulmonary hypertension using genomic and proteomic approaches to identify unique molecules as potential targets for new therapies for pulmonary hypertension associated with sickle cell disease, scleroderma, and left ventricular diastolic dysfunction. Dr Farber is an NIH-funded principle investigator on numerous grants, and is a member of several research groups both within the Pulmonary Hypertension Center and other divisions within the Department of Medicine.